March of Dimes Launches ‘Low Dose, Big Benefits’ Initiative to Combat Preeclampsia
March of Dimes launches ‘Low Dose, Big Benefits’ initiative to combat preeclampsia, a serious condition affecting pregnant women. The campaign aims to raise awareness about the benefits of low-dose aspirin in reducing the risks associated with preeclampsia, with support from partners like Sanofi and HCA healthcare system. Brand ambassador Allyson Felix will share her personal experience with preeclampsia and the positive impact of LDA on her second pregnancy.
Labcorp Introduces Groundbreaking First-Trimester Screening Test for Preeclampsia Risk Assessment
Learn about Labcorp’s groundbreaking first-trimester screening test for preeclampsia, a serious high blood pressure disorder that affects many pregnancies in the United States. This innovative test utilizes early pregnancy biomarkers to predict the development of preeclampsia before 34 weeks of pregnancy, offering up to 90% sensitivity in risk assessment. Find out how Labcorp’s new screening test complements existing FDA-cleared tests and aims to enhance maternal and fetal health outcomes through early risk identification and management.
Study Reveals Lower Calcium Dosage for Pregnant Women to Reduce Preeclampsia Risk
A recent study conducted by a team of researchers from St. John’s Research Institute and Medical College has revealed groundbreaking findings regarding the required dosage of calcium for pregnant women to reduce the risk of preeclampsia. The study suggests that…
Groundbreaking Advancement in Pre-Eclampsia Study with ‘Mini-Placentas’
Cambridge lab researchers have made a groundbreaking advancement in the study of pre-eclampsia by growing ‘mini-placentas’ in a laboratory setting. This development could potentially lead to a better understanding of the condition, which affects about six in 100 first pregnancies….